My COVID-19 prevention policy.
Here is the background information why I think testing my product for SARS-CoV-2 antiviral properties.
Manuka honey has known anti-microbial and anti-viral properties. Recently, Quantum Technologies developed a scalable process to isolate the active from Manuka honey that when used in topical applications accelerates healing, reduces inflammation and reduces pain, demonstrated through clinical case study evaluation. The stability of the biomaterials and the mode of action and composition have been determined through extensive analysis. This product will be (Step 1) tested for anti-viral activity (NeoVirTech). Step 2) inhalation safety determined in an animal pulmonary delivery model (Otago University). Step 3) Demonstration of efficacy in a SARS-CoV-2 screen. Step 4) Clinical evaluation in NZ with Pharmaceutical Solutions and Maori-healers community. Maori economy is currently being affected by COVID-19 through the downturn in tourism and primary industry exports. Maori prize Manuka as a Taonga. Rongoa community are receptive to this opportunity and Manuka honey will be sourced from various companies with the evidence obtained be used to register the product as a complimentary medicine.
I need to raise a considerable amount of money to conduct this research. If you want to contribute and help produce an alternative to vaccination.